Objectives To assess the potential role of clinical trial (CT) registries and other resources available to research ethics committees (RECs) in the evaluation of complex CT protocols in low-income and middle-income countries.
Methodology Using a case study approach, the authors examined the decision-making process of a REC in Argentina and its efforts to use available resources to decide on a complex protocol. We also analysed the information in the USA and other CT registries and consulted 24 CT experts in seven countries.
Findings Information requested by the Argentinean REC from other national RECs and ethics’ experts was not useful to verify the adequacy of the REC's decision whether or not to approve the CT. The responses from the national regulatory agency and the sponsor were not helpful either. The identification of international resources that could assist was beyond the REC's capability. The information in the USA and other CT registries is limited, and at times misleading; and its accuracy is not verified by register keepers.
Discussion and conclusion RECs have limited access to experts and institutions that could assist them in their deliberations. Sponsors do not always answer RECs’ request for information to properly conduct the ethical and methodological assessment of CT protocols. The usefulness of the CT registries is curtailed by the lack of appropriate codes and by data errors. Information about reasons for rejection, withdrawal or suspension of the trial should be included in the registries. Establishing formal channels of communication among national and foreign RECs and with independent international reference centres could strengthen the ethical review of CT protocols.
- Clinical trials
- Drugs and Drug Industry
- Ethics Committees/Consultation
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Clinical trial transparency in the Americas: the need to coordinate regulatory spheres
- Strengthening ethics committees for health-related research in sub-Saharan Africa: a scoping review
- Legislative regulation and ethical governance of medical research in different European Union countries
- The structure of ethics review: expert ethics committees and the challenge of voluntary research euthanasia
- Research ethics committees in Europe: implementing the directive, respecting diversity
- Implementation of the EU clinical trial regulation transforms the ethics committee systems and endangers ethical standards
- Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I
- Trial registration and adherence to reporting guidelines in cardiovascular journals
- Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
- Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries